FIELD: medicine, gastroenterology.
SUBSTANCE: the present innovation deals with predicting the development of postgastroresectional peptic ulcers in patients due to detecting the level of gastrin after stimulation, pepsinogen, prostaglandins PGE2 and PG F2α, correspondingly, in mucosa of gastric stump and in mucosa of gastroenteroanastomosis. At increasing gastrin level up to 12.5 pM/l and higher, that of pepsinogen up to 10.0 mcg/l and higher and decreasing the level of prostaglandin PGE2 up to 570 and lower and at the decrease of prostaglandin PG F2α level up to 652 ng/g and lower one should predict the development of postgastroresectional peptic ulcer. Application of the present innovation enables to increase the accuracy in predicting the development of postgastroresectional peptic ulcers.
EFFECT: higher accuracy of prediction.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING CHOLECYSTITIS AND CHOLELITHIASIS | 2004 |
|
RU2263920C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTIC OF CHRONIC HEPATITIS AND HEPATIC CIRRHOSIS | 2003 |
|
RU2254577C1 |
| DIAGNOSTIC TECHNIQUE FOR DEGREE OF ACTIVITY OF ANTRAL HELICOBACTER-ASSOCIATED GASTRITIS IN PATIENTS WITH BRONCHIAL ASTHMA | 2009 |
|
RU2394499C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF NONHEALING PEPTIC STOMACH AND DUODENAL ULCER | 2003 |
|
RU2255661C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR LIVER DISEASES OF VARIOUS AETIOLOGIES ACCOMPANIED WITH INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386969C2 |
| METHOD FOR TREATING GASTRIC POLYPOSIS | 2003 |
|
RU2268743C2 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS | 2018 |
|
RU2706026C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF STOMACH- OR DUODENAL ULCER ASSOCIATED WITH HELICOBACTER PYLORI | 2003 |
|
RU2269132C2 |
| METHOD OF TREATING GASTRIC OR DUODENAL ULCER IN HEAVY SMOKERS | 2014 |
|
RU2554456C1 |
